We’re excited to announce DeepPsy’s first medical rollout in the Swiss healthcare market! This marks a major milestone in our journey to revolutionize psychiatric care with data-driven solutions.
Introducing the "DeepPsy Biomarker Report"
Our advanced EEG and ECG analysis service is designed to assist mental healthcare providers in delivering personalized treatments. By analyzing critical biomarkers, we help identify the most effective options for depression treatments, including SSRIs, SNRIs, rTMS, Ketamine, and ECT.
Regulatory Excellence
DeepPsy has self-certified compliance with all applicable regulations, adhering to ISO 13485 standards for medical devices. This ensures our services meet the highest standards of safety and quality for medical applications.
Our Mission
With this rollout, we’re bringing precision psychiatry to life, supporting mental healthcare providers in making informed decisions. Our approach not only improves patient outcomes but also reduces hospital stays, aligning with our vision of a more effective and efficient healthcare system.
Join us in celebrating this exciting new chapter as we continue to innovate and empower mental health professionals to transform lives. Stay tuned for more updates from DeepPs
